People: Aceto Corp (ACET.O)


ACET.O on Nasdaq

13.06USD
18 Jun 2013
Price Change (% chg)

$0.31 (+2.43%)
Prev Close
$12.75
Open
$12.73
Day's High
$13.07
Day's Low
$12.73
Volume
118,659
Avg. Vol
123,707
52-wk High
$13.47
52-wk Low
$8.25

Search Stocks

Summary

Name Age Since Current Position

Albert Eilender

 69 2013 Chairman of the Board

Salvatore Guccione

 49 2013 President, Chief Executive Officer, Chief Operating Officer, Director

Douglas Roth

 55 2010 Chief Financial Officer, Senior Vice President

Steven Rogers

 51 2011 Senior Vice President, General Counsel, Corporate Secretary

Charles Alaimo

 46 2012 Senior Vice President - Human Resources

Raymond Bartone

 50 2012 Senior Vice President - Nutritionals

Frank DeBenedittis

 58 2011 Senior Vice President - Corporate Business Development

David Rosen

 54 2012 Senior Vice President - Business Development

Nicholas Shackley

 48 2011 Senior Vice President - Pharmaceutical Ingredients

Roger Weaving

 53 2010 Senior Vice President - Performance Chemicals

Guillaume Saint-Clair

 41 2011 Vice President - Pharmaceutical Intermediates Business

Jan Van Eis

 54 2010 Vice President - Active Pharmaceutical Ingredients and Emerging Markets

Ronald Gold

 53 2010 President and Chief Operating Officer of Rising Pharm

Lukas von Hippel

 51 2011 Managing Director, Pharma Waldhof GmbH

Hans Noetzli

 71 2009 Lead Independent Director

Natasha Giordano

 52 2010 Director

William Britton

 67 2006 Independent Director

Richard Randall

 74 2009 Independent Director

Robert Wiesen

 61 1994 Independent Director

Amy Glynn

 IR Officer
» Insider Trading

Biographies

Name Description

Albert Eilender

 Mr. Albert L. Eilender is Chairman of the Board of Aceto Corp. Mr. Eilender has been Chairman and Chief Executive Officer since September 2010. Prior to that, Mr. Eilender was the Company’s lead independent director since 2005 and since October 2009, served as the Non-Executive Chairman of the Board. In September 2012, the Company announced that, effective January 2, 2013, Mr. Eilender will step down from his position as Chief Executive Officer while retaining his duties as Chairman. He is the sole owner of Waterways Advisory Services, a firm specializing in advising companies on developing and evaluating options relative to mergers, acquisitions and strategic partnerships in the chemical industry. Mr. Eilender has not been active in the operations of this enterprise since October 2009.

Salvatore Guccione

 Mr. Salvatore J. Guccione is President, Chief Executive Officer, Chief Operating Officer, Director of Aceto Corp. Mr. Guccione has been the President and Chief Operating Officer of Aceto since December 2011. Mr. Guccione was formerly an Operating Partner at Arsenal Capital Partners, a private equity investment firm based in New York. Prior to that, Mr. Guccione was the Chief Executive Officer and the Chief Financial Officer of WIL Research Laboratories from 2006 to 2009 and the Chief Financial Officer of International Specialty Products from 2004 to 2005. In addition, Mr. Guccione held various positions at Cambrex Corporation from 1995 to 2004, including Executive Vice President, Strategy and Chief Financial Officer. From 1987 to 1995, Mr. Guccione held various positions at International Specialty Products, including Vice President and General Manager, Personal Care and Director, Corporate Development. Mr. Guccione holds a Bachelor degree in Chemical Engineering from Lehigh University and an MBA in Finance from New York University’s Stern School of Business. Mr. Guccione joined Aceto’s Board in May 2011. Mr. Guccione serves on the board of ReSearch Pharmaceutical Services, Inc. In addition, Mr. Guccione previously served on the boards of Royal Adhesives & Sealants Holdings and DG3 Holdings from 2010 to October 2011.

Douglas Roth

 Mr. Douglas A. Roth is Chief Financial Officer, Senior Vice President of Aceto Corp. Mr. Douglas Roth has been Senior Vice President and Chief Financial Officer since March, 2010 and had previously been Vice President and Chief Financial Officer since joining the Company in May, 2001. Prior to joining the Company, Mr. Roth was the Vice President and Chief Financial Officer of CitySprint 1-800 Deliver from September 1998 through April 2001. Mr. Roth holds a bachelor degree in accounting from the State University of New York at Oswego and an MBA in finance from Fordham University.

Steven Rogers

 Mr. Steven Rogers is Senior Vice President, General Counsel, Corporate Secretary of Aceto Corp. Prior to joining the Company, Mr. Rogers was the General Counsel of Rising, certain assets of which the Company acquired in December 2010. Mr. Rogers oversees all legal and regulatory matters and provides legal counsel to the Company’s senior management and Board of Directors. From 1986 to 1994, Mr. Rogers was a corporate litigator at Kelley Drye & Warren LLP. From 1994 to 1997, he was Associate General Counsel/First Vice-President of PaineWebber, Inc. From 1997 to 2009, he served as General Counsel of LibertyView Capital Management, a SEC-registered investment adviser, owned by Credit Agricole and then Neuberger Berman, LLC, where he was responsible for all legal, compliance and regulatory matters and oversaw the research and risk departments. Mr. Rogers earned his J.D. from the Fordham University School of Law in 1986 and a B.A. in History from the State University of New York at Binghamton in 1983.

Charles Alaimo

 Mr. Charles J. Alaimo is Senior Vice President - Human Resources of Aceto Corp. He has served as Vice President, Human Resources, since January 2011. Mr. Alaimo oversees the global human resources functions. Prior to joining the Company, from 2008 to 2011, Mr. Alaimo was Director, Global Human Resources for Coby Electronics where he oversaw all human resources activities for this private consumer electronics company. From 2004 to 2007, he was Director, Human Resources and General Affairs for TDK Electronics Corporation. Mr. Alaimo also served as Regional Manager, Human Resources for Group One Trading, LP a private, derivatives trading firm from 2000 to 2004. Mr. Alaimo earned his B.B.A. in Human Resources Management from Baruch College in 1989 and a M.S. in Industrial and Labor Relations from Baruch College in 2005.

Raymond Bartone

 Mr. Raymond Bartone is Senior Vice President - Nutritionals of Aceto Corp. Mr. Bartone joined the Company in 1991 as a sales representative and held positions within the Company. Mr. Bartone has a B.A. in Chemistry from Manhattanville College and a M.S. in Chemical Engineering from Manhattan College.

Frank DeBenedittis

 Mr. Frank DeBenedittis is Senior Vice President - Corporate Business Development of Aceto Corp. Mr. DeBenedittis has served as Senior Vice President, Corporate Business Development since August 2011 and International Senior Vice President, Active Pharmaceutical Ingredients since February 2011. Prior to that, Mr. DeBenedittis was Executive Vice President since January 2009 and Senior Vice President of the Company since 2001. Mr. DeBenedittis joined the Company in 1979 as a marketing assistant and held positions within the Company including Assistant Product Manager, Product Manager, Assistant Vice President and Vice President. In addition, Mr. DeBenedittis currently serves on the Board of Directors of Rising Pharmaceuticals, Inc., a wholly owned subsidiary, which was acquired on December 31, 2010. Mr. DeBenedittis holds a B.A. in Chemistry from Stony Brook University.

David Rosen

 Mr. David B. Rosen is no longer Senior Vice President - Business Development of Aceto Corp., effective December 31, 2013. Mr. Rosen has been Executive Vice President of Rising since March 2000. Prior to Rising being acquired by the Company in December 2010, Mr. Rosen was, since March 2000, a minority owner of Rising and served as Executive Vice President of Rising. Since the acquisition, Mr. Rosen serves as Senior Vice President. As Executive Vice President of Rising, he oversaw all aspects of product development, information technology and quality control at Rising. Mr. Rosen is also a majority owner of ipMedica, Inc., a medical transcription company, since August 1999, to which Mr. Rosen provides general oversight and strategic planning services. In addition, Mr. Rosen has a minority investment in Mirror Pharmaceuticals LLC, an FDA-approved manufacturer of solid dose pharmaceutical products. Mr. Rosen has a B.A. (Summa Cum Laude) in Economics and Political Science from Queens College (CUNY).

Nicholas Shackley

 Mr. Nicholas I. Shackley is Senior Vice President - Pharmaceutical Ingredients of Aceto Corp. Prior to joining Aceto, Mr. Shackley has had a 25 year professional career starting in England with the former British company ICI Specialties. He then transferred to the USA and joined Zeneca Specialties which was the predecessor company of Avecia Inc for 8 years, primarily in executive sales and business development roles. In 2004 he joined Cambrex where he continued to take leadership positions in Sales, Marketing & Business Development in both Pharma and Biopharma capacities. Mr. Shackley has had P&L responsibility with BASF for their Pharmaceutical Ingredients and Service Business Unit as their Vice President-North America. Nicholas holds a Chemical Engineering degree from the Imperial College of London.

Roger Weaving

 Mr. Roger G. Weaving, Jr., is Senior Vice President - Performance Chemicals of Aceto Corp. Mr. Weaving joined the Company in 1984 and over the years has held various positions in the Specialty Chemicals business unit. Mr. Weaving has been a member of the Board of Governors for the Color Pigments Manufacturers Association, Inc. since 2004. Prior to that, Mr. Weaving received an A.B. degree from Dartmouth College and an M.S. in Chemistry from the University of Rochester.

Guillaume Saint-Clair

 Mr. Guillaume Saint-Clair is Vice President - Pharmaceutical Intermediates Business of Aceto Corporation. Mr. Saint - Clair joined Aceto in 2001 as a result of the Company’s acquisition of certain businesses of Schweizerhall, and has held management positions, most recently being responsible for managing Aceto’s European pharmaceutical intermediates and specialty chemicals businesses since January 2010. Mr. Saint - Clair holds a Masters of Physical Organic Chemistry from the University Jean Fourrier in Grenoble.

Jan Van Eis

 Mr. Jan Van Eis is Vice President - Active Pharmaceutical Ingredients and Emerging Markets of Aceto Corp. Mr. Van Eis joined Aceto in March, 2001 as a Vice President, as a result of Aceto’s acquisition of certain distribution businesses of the Schweizerhall Holdings and has been Managing Director of Aceto BV since January 2007. Prior to joining Aceto, Mr. Van Eis was Sales and Business Development Manager for International Pharmaceutical Chemicals BV (which was subsequently acquired by Schweizerhall Holdings) since 1992.

Ronald Gold

 Mr. Ronald Gold is no longer President and Chief Operating Officer of Rising Pharm., a subsidiary of Aceto Corp., effective December 31, 2013. Mr. Gold was a majority owner of Rising and is now President and COO of Rising since the acquisition. As President and COO of Rising, he oversees all aspects of Rising. In addition, Mr. Gold is a (a) minority owner of ipMedica, Inc., a medical transcription company to which Mr. Gold provides periodic advice concerning strategic planning; (b) Managing Member and President of T&G Group, Inc. since October 1992, a real estate investment and management company for which Mr. Gold provides general oversight, and (c) minority owner and a Managing Member of Mirror Pharmaceuticals LLC, for which he provides general advice on a periodic basis. Mr. Gold has a B.S. in Accounting from Northeastern University.

Lukas von Hippel

 Mr. Lukas von Hippel is Managing Director, Pharma Waldhof GmbH., awholly owned subsidiary of Aceto Corp. Prior to that, Dr. von Hippel was Site Manager for site Hanau at Kruse, a German distributing company. Before joining Kruse, he was executive of AllessaChemie, a former Clariant site where he was beside others responsible for Marketing and Sales. Prior to this he worked for Degussa in various functions, including R&D, Consulting and Marketing & Sales. Dr. von Hippel holds a doctor’s degree from Munich University for Chemistry.

Hans Noetzli

 Mr. Hans C. Noetzli is Lead Independent Director of Aceto Corporation. Mr. Noetzli is the former Chairman of Schweizerhall, Inc., a wholly owned subsidiary of Schweizerhall Holding AG, Basel, Switzerland. Mr. Noetzli holds a degree in Business Administration. He has more than 30 years of experience in the fine chemicals industry. Prior to his role as Chairman of Schweizerhall, Inc., he served in many executive functions of the Alusuisse-Lonza Group, among them as Chief Executive Officer of Lonza Inc. for 16 years and he was a member of the executive committee of the worldwide Alusuisse-Lonza Group located in Zurich, Switzerland. Mr. Noetzli also served on the board of directors of the Chemical Manufacturing Association, the Swiss-American Chamber of Commerce, New York, as well as other industry associations. Currently, he is the Chairman of the Audit Committee of the board of directors of IRIX Pharmaceuticals, Inc., a privately owned developer and manufacturer of active pharmaceutical ingredients. In addition, Mr. Noetzli was a member of the board of directors of Synthetech, Inc., chemicals company specializing in organic synthesis, biocatalysis and chiral technologies, from 2004 through 2010.

Natasha Giordano

 Ms. Natasha Giordano is Director of Aceto Corp. Ms. Giordano served as the Chief Executive Officer, President and Director of Xanodyne Pharmaceuticals, Inc. a branded specialty pharmaceutical company with development and commercial capabilities focused on pain management, from May 2010 to August 2012 and Chief Operating Officer since 2009. Prior to that, she served as President, Americas for Cegedim Dendrite (formerly Dendrite International Inc.) from 2007 to 2008 and as Senior Vice President of the Global Customer Business Unit of Cegedim Dendrite from 2004 to 2007. She had been with Cegedim Dendrite since 2000 and served as Group President for Global Business Unit for customers, and Vice President of Global Sales. Earlier in her career, she worked nine years with Parke-Davis then owned by Warner Lambert in several sales and marketing positions including Strategic Alliance management and Sales Integration. Ms. Giordano holds a Bachelors of Science degree from Wagner College in New York and is a Registered Nurse.

William Britton

 Mr. William N. Britton is Independent Director of Aceto Corporation. Mr. Britton is the sole owner of TD AIM, LLC through which he is involved in activities surrounding financial consulting and private equity investing. Mr. Britton is also a Vice Chairman of P and E Capital, Inc., a management company involved in real estate. Previously, Mr. Britton was a Senior Vice President with JP Morgan Chase. He has over 30 years of commercial lending experience ranging from syndicated financings with Fortune 500 companies to privately owned businesses, with experience in private equity related transactions, asset based lending arrangements, leasing and many other forms of secured lending. Mr. Britton is on the Northeast Advisory Council of Opera Solutions, a private firm engaged in consulting. Mr. Britton is a former Vice President-Finance for the Boy Scouts of America (Manhattan Council) and is on the board of the Rutgers Business School.

Richard Randall

 Mr. Richard P. Randall is Independent Director of Aceto Corp. Mr. Randall is the former Chief Operating Officer and Chief Financial Officer of Direct Holdings Worldwide, LLC, the parent company of Lillian Vernon Corp. and Time-Life, from 2002 until 2005. Prior to that, Mr. Randall was the Chief Financial Officer of Coach, Inc. from 2000 to 2001 and the Chief Financial Officer of Lillian Vernon Corp. from 1998 to 2000. Mr. Randall holds a degree in accounting and is a Certified Public Accountant. He has more than 40 years of experience in various accounting and finance positions. Mr. Randall joined Aceto’s board in May 2009 and currently serves as chair of its Audit & Risk Committee and as a member of the Nominating & Governance Committee. Mr. Randall serves as the Chairman of the Audit Committee of the Board of Directors for Steven Madden, Ltd. since 2006. Mr. Randall has also served as the Chairman of the Audit Committee of the Board of Directors for The Burke Rehabilitation Hospital in White Plains, NY through December 31, 2011 where he has served since 2005. Mr. Randall joined the board of P&F Industries, Inc. in May 2012. Mr. Randall also served as a director and chair of the Audit Committee for two unrelated Chinese companies publicly traded in the US, Universal Travel Group and Home Systems Group, from 2007 until 2008 when he resigned from these boards.

Robert Wiesen

 Mr. Robert A. Wiesen is Independent Director of Aceto Corporation. Mr. Wiesen is a senior partner in the law firm of Clifton Budd & DeMaria, LLP, and has practiced employment law for over thirty years. In the course of his law practice, Mr. Wiesen has represented hundreds of employers in a wide array of industries, including chemical, pharmaceutical, distribution and manufacturing. In the course of his professional activities, Mr. Wiesen has gained advanced business, financial, management, human resources, executive compensation, benefits, regulatory and legal experience. He is a member of the American Bar Association and has written and lectured on business related employment issues over the years. Mr. Wiesen received his legal and undergraduate degrees magna cum laude and cum laude and has received many honors including Phi Beta Kappa membership, National Labor Relations Board superior performance awards, and the American Jurisprudence Award for Labor Law.

Amy Glynn

Insider Trading

Name Shares Traded Price

WEAVING ROGER W JR

 4,420 $13.02

WEAVING ROGER W JR

 4,895 $10.94

SAINT CLAIR GUILLAUME

 9,000 $10.94

SAINT CLAIR GUILLAUME

 1,500 $8.05

SAINT CLAIR GUILLAUME

 1,666 $13.05

SAINT CLAIR GUILLAUME

 1,666 $6.18

SAINT CLAIR GUILLAUME

 1,500 $13.04

SAINT CLAIR GUILLAUME

 1,666 $13.04

SAINT CLAIR GUILLAUME

 1,666 $7.76

SAINT CLAIR GUILLAUME

 9,000 $12.99

SAINT CLAIR GUILLAUME

 1,500 $13.04

SAINT CLAIR GUILLAUME

 1,500 $8.62

ROTH DOUGLAS A

 90 $13.27

ROTH DOUGLAS A

 30,000 $10.94

VAN EIS JAN

 9,000 $10.94

VAN EIS JAN

 9,000 $13.39

ROTH DOUGLAS A

 30,000 $13.31

GOLD RONALD

 25,000 $11.71

DEBENEDITTIS FRANK V

 5,400 $11.86

DEBENEDITTIS FRANK V

 5,400 $8.22

DEBENEDITTIS FRANK V

 2,900 $11.85

DEBENEDITTIS FRANK V

 3,600 $11.99

DEBENEDITTIS FRANK V

 4,267 $12.00

DEBENEDITTIS FRANK V

 3,600 $8.22

SAINT CLAIR GUILLAUME

 2,250 $8.22
» Full list on Insider Trading
Search Stocks